NDT Effectiveness Study

MultiCare Health System Research Institute14 enrolled

Overview

The purpose of this study is to determine whether there is a functional change in children with Cerebral Palsy (CP) and other neuromuscular disorders participating in Neurodevelopmental Treatment (NDT) intervention using the contemporary practice model (CPM).

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Cerebral Palsy Neuromuscular Diseases Neurodevelopment Treatment

Interventions

TherapyBEHAVIORAL

The intervention performed in the practicum will not be able to be influenced by the study investigators and the intervention may be different for each child based on their needs

Eligibility

Sex: ALLMin age: 2 YearsMax age: 15 Years

Medical Language ↔ Plain English

Inclusion Criteria: * The children will be aged 2 to 15 years with a diagnosis of CP, hypotonia, global developmental delay and/ or neuromuscular disorders not otherwise specified. * Children must also be willing to receive physical guidance for movement and clearly attempt to respond to simple instructions on request. * Children and their families are available and willing to attend the practicum portion of the course for both blocks. Exclusion Criteria: * Parent/Guardian unable to complete the 4 required interview sessions. * Unable to commit to attending 75% of practicum sessions.

Locations (1)

Good Samaritan Hospital

Puyallup, Washington, United States

Outcomes

Primary Outcomes

Significant increase in functional outcomes in COPM scores

Change functional outcomes in COPM scores after NDT-CPM treatment.

Time frame: Significant change after an 8 week NDT-CPM treatment occurring from November 2, 2021 to completion on March 12, 2022

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.